Health policy and management

Ohio Officials, CMHA, 360º Management, and CVS Health Announce Opening of Supportive Housing Community for Human Trafficking Survivors

Retrieved on: 
Monday, November 27, 2023

COLUMBUS, Ohio, Nov. 27, 2023 /PRNewswire/ -- Today, a bipartisan group of elected officials joined representatives from CVS Health® (NYSE: CVS), Columbus Metropolitan Housing Authority (CMHA), Beacon 360 Management, and community leaders to announce the opening of Harriet's Hope – a 52-unit, multifamily supportive housing community – empowering survivors of human trafficking. Named in honor of abolitionist Harriet Tubman, who helped many escape slavery, Harriet's Hope is a first-of-its-kind development for Columbus and among the nation's first service-enriched housing communities exclusive to human trafficking survivors. Residents will live in a community with access to robust onsite case management and social services that address the unique needs of human trafficking survivors, while also encouraging rehabilitation and self-sufficiency. With construction now complete, residents will begin moving in December.

Key Points: 
  • Public-private partnership builds upon Ohio's efforts addressing human trafficking, housing across the state
    COLUMBUS, Ohio, Nov. 27, 2023 /PRNewswire/ -- Today, a bipartisan group of elected officials joined representatives from CVS Health® (NYSE: CVS), Columbus Metropolitan Housing Authority ( CMHA ), Beacon 360 Management , and community leaders to announce the opening of Harriet's Hope – a 52-unit, multifamily supportive housing community – empowering survivors of human trafficking.
  • Building the $15.6 million property was made possible through CVS Health's $10.6 million investment, facilitated through the Ohio Capital Corporation for Housing ( OCCH ).
  • Recognizing housing's impact on community health outcomes, CVS Health invested $10.6 million to build Harriet's Hope as the initiative's sole equity funder.
  • Harriet's Hope is a further demonstration of the company's commitment to address housing insecurities – and support Ohio human trafficking survivors.

PicnicHealth Announces Three New Advisors and Expands Expertise in Regulatory-ready Research

Retrieved on: 
Monday, November 6, 2023

PicnicHealth , a leading patient-centered healthcare evidence generation company, appointed three advisors in clinical research design – Nancy Dreyer, Solomon Iyasu, and Jeremy Brody.

Key Points: 
  • PicnicHealth , a leading patient-centered healthcare evidence generation company, appointed three advisors in clinical research design – Nancy Dreyer, Solomon Iyasu, and Jeremy Brody.
  • These new advisors are joining PicnicHealth in an advisory capacity to support the company’s expansion into regulatory use cases.
  • Dr. Dreyer is an internationally recognized expert in the use of real-world evidence for regulatory purposes.
  • Dr. Dreyer holds a Ph.D. in epidemiology and Master of Public Health from the University of North Carolina, Chapel Hill.

Hapbee Receives Prestigious Nexus Certification Award from Grey Team as Top Military Suicide Prevention Tool for 2023

Retrieved on: 
Monday, July 17, 2023

Grey Team is a privately funded, 501(c)3 nonprofit organization aiming to improve the personal health and wellness of active-duty soldiers and military veterans to reduce suicides.

Key Points: 
  • Grey Team is a privately funded, 501(c)3 nonprofit organization aiming to improve the personal health and wellness of active-duty soldiers and military veterans to reduce suicides.
  • The Grey Team's Nexus Award represents one of America's most rigorous, in-field certifications for cutting-edge wellness solutions.
  • Grey Team has been using Hapbee Neckbands and Smart Sleep Pads as part of its high-successful Operation Phoenix program for nearly two years.
  • Refer to the Company's news release dated March 8, 2021, for further information on its partnership with Grey Team.

Cybin Announces Appointment of Sanford R. Climan as Strategic Advisor

Retrieved on: 
Tuesday, June 27, 2023

Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that Mr. Sanford R. Climan has joined Cybin as a strategic advisor.

Key Points: 
  • Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that Mr. Sanford R. Climan has joined Cybin as a strategic advisor.
  • Widely viewed as a media visionary, Mr. Climan is an active venture investor, board member, and senior advisor to a wide range of transformational companies spanning healthcare, media, and technology.
  • Mr. Climan previously served as a member of the Advisory Committee to the Director of the Centers for Disease Control and Prevention.
  • Mr. Climan commented, “Cybin is a leader in the development of new therapeutics that have the potential to meaningfully impact the current crisis in mental health and wellness.

Hapbee Expands Distribution to Seniors, Caregivers, and Communities Through Gray Matters Alliance

Retrieved on: 
Thursday, May 18, 2023

Gray Matters Alliance (GMA) provides enabling technology products and services for the intellectually and developmentally disabled and aging populations.

Key Points: 
  • Gray Matters Alliance (GMA) provides enabling technology products and services for the intellectually and developmentally disabled and aging populations.
  • "Sleep plays a huge role in people's lives," said Vicki Spraul, President and Founder, Gray Matters Alliance.
  • "Gray Matters Alliance expands our ability to reach Seniors, Caregivers, and Service Providers who can benefit from our life-enhancing technology.
  • Hapbee is not subject to any insolvency proceeding and there is no other material information concerning the affairs of Hapbee that has not been generally disclosed.

Americana Partners, a Texas-Based Wealth-Management Powerhouse with $6 Billion in Assets, Adds Four-Member Team Currently Managing $715 Million in Midland, Texas, To Drive Focus on Oil and Gas Families

Retrieved on: 
Monday, February 27, 2023

Previously known as The Fidelis Wealth Management Group, the team managed $715 million in client assets while at Morgan Stanley.

Key Points: 
  • Previously known as The Fidelis Wealth Management Group, the team managed $715 million in client assets while at Morgan Stanley.
  • The four advisors and their team will drive the creation of Americana Partners’ new Permian Basin office in Midland, Texas.
  • For Jason Fertitta, CEO and Partner of Americana Partners, the new office underlines Americana Partners’ commitment to the communities it serves.
  • Americana Partners is an independent RIA headquartered in Houston, Texas, with as much as $6 Billion in assets under management.

Alexandra Clyde appointed to Sequana Medical Board of Directors

Retrieved on: 
Thursday, August 25, 2022

Ghent, Belgium 25 August 2022 Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, today announces the appointment of Alexandra Clyde as an independent Non-Executive Director of the Company.

Key Points: 
  • Ghent, Belgium 25 August 2022 Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, today announces the appointment of Alexandra Clyde as an independent Non-Executive Director of the Company.
  • Alex will be a critical member of our Board as Sequana Medical prepares to expand commercialization of the alfapump, said Pierre Chauvineau, Chairman of the Board at Sequana Medical.
  • With Doug and Alex now on the Board, I am confident that the Board is well positioned to guide Sequana Medical as it enters a period of potential exponential growth.
  • The appointment of Ms. Clyde is subject to the approval of the Board of Directors and will also be submitted for approval to the Companys next Meeting of Shareholders.

Center for Breakthrough Medicines Adds Two Senior Vice Presidents to Leadership Team

Retrieved on: 
Wednesday, July 27, 2022

KING OF PRUSSIA, Pa., July 27, 2022 /PRNewswire/ -- The Center for Breakthrough Medicines (CBM) announced today the appointment of Mandy Conver as Senior Vice President (SVP) of Business Development for Testing & Analytics, and Jennifer Manning as SVP of Global Strategic Partnerships.

Key Points: 
  • "Each brings extensive expertise in strategy formulation, team development, process management and commercial leadership, and are expected to have a significant impact on the continued growth of CBM."
  • She will be responsible for leading and directing a team of highly technical Business Development professionals to repeated success while driving revenue growth.
  • "I'm honored to join CBM and lead the continued, rapid expansion of the testing and analytical services business," said Conver.
  • I'm excited to partner with their team of industry experts to help accelerate life-saving therapies to patients."

TNG Consulting Announces Promotion of Tanyka M. Barber to Partner

Retrieved on: 
Thursday, October 7, 2021

KING OF PRUSSIA, Pa., Oct. 7, 2021 /PRNewswire/ --TNG Consulting LLC is pleased to announce the promotion of Senior Supervising Consultant Tanyka M. Barber, M.H.S., J.D.

Key Points: 
  • KING OF PRUSSIA, Pa., Oct. 7, 2021 /PRNewswire/ --TNG Consulting LLC is pleased to announce the promotion of Senior Supervising Consultant Tanyka M. Barber, M.H.S., J.D.
  • With this promotion, Barber becomes TNG's practice leader for developing products and services for K-12 schools and districts, an expanding market for TNG.
  • Barber joined TNG as a consultant in January 2019 and has consistently grown her firm and field contributions.
  • TNG Consulting LLC is a consulting and association management firm with over 20 years of experience.

CloudMD Adopts Advance Notice Policy

Retrieved on: 
Tuesday, October 5, 2021

VANCOUVER, British Columbia, Oct. 05, 2021 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the Company or CloudMD), a healthcare technology company transforming the delivery of care, announces that the Board of Directors of the Company has adopted an advance notice policy (the "Policy").

Key Points: 
  • VANCOUVER, British Columbia, Oct. 05, 2021 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the Company or CloudMD), a healthcare technology company transforming the delivery of care, announces that the Board of Directors of the Company has adopted an advance notice policy (the "Policy").
  • The purpose of the Policy is to provide shareholders, directors and management of CloudMD with a framework for nominating directors of the Company.
  • The Policy, among other things, includes a provision that requires advance notice to the Company in certain circumstances where nominations of persons for election to the Board of Directors are made by holders of record of common shares of the Company.
  • No person will be eligible for election as a director of CloudMD unless nominated in accordance with the Policy.